
Clearbridge Health completes placement of 309.5 million shares
The company’s total issued shares have increased to 2.17 billion shares.
Clearbridge Health Limited has completed its placement of 309.5 million new ordinary shares at $0.0031 per share, as announced on 19 December 2024 and 9 January 2025.
Following the placement, the company’s total issued shares have increased from 1.86 billion to 2.17 billion shares. The new shares will be listed and quoted on the SGX-ST’s Catalist board starting 14 January 2025, with trading set to begin at 9:00 a.m.
The new shares will rank pari passu with existing shares but will not entitle holders to any dividends or distributions declared before the allotment date.